Top Section/Ad
Top Section/Ad
Most recent
Military goggles maker Theon starts €150m rights issue
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
AMS, the Austrian sensor maker, has launched a Sfr1.75bn (€1.65bn) rights issue, despite volatile equity markets but bankers hope that the attractive entry price and the steady nature of the company itself will be enough to ensure a successful deal, despite difficult equity markets. -
Companies with weak balance sheets will find it difficult to raise equity capital in the weeks ahead after oil prices plunged 30% overnight, tipping global stockmarkets into bear market territory. The difficulty is likely to be particularly acute for companies in sectors heavily exposed to the spread of the Covid-19 virus, such as energy, travel and tourism.
-
Danish pharmaceuticals company Bavarian Nordic has announced an Nkr2.8bn (€378m) rights issue to fund its acquisition of GlaxoSmithKline’s commercial and manufacturing rights to Rabipur, a treatment for rabies, and Encepur, a vaccine against tick-borne encephalitis.
-
Shares in Norwegian Air Shuttle, the Norwegian airline, fell more than 25% on Friday morning after the company scrapped its profit guidance for 2020 because of the mounting economic damage caused by the spread of the Covid-19 coronavirus.
-
Capita raised £719m of equity in May 2018 via a deal that was billed as the path to securing its financial future after a difficult period for the outsourcing sector. However, the firm has now conceded that the amount raised was not enough to offset its decline in revenues.
-
Shares in Intu Properties, the UK real estate investment trust focused on shopping centres, tanked this week after the company said on Wednesday morning that it has called off its £1bn-plus rights issue due to “extreme” market conditions.
